Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2008-11-26
2011-11-22
Katakam, Sudhakar (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S336000, C514S557000, C562S512000, C562S590000, C562S597000
Reexamination Certificate
active
08063250
ABSTRACT:
Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof.
REFERENCES:
patent: 4535186 (1985-08-01), Husbands et al.
patent: 6197828 (2001-03-01), Jerussi et al.
patent: 6673838 (2004-01-01), Hadfield et al.
patent: 6689912 (2004-02-01), Weber
patent: 7026508 (2006-04-01), Winkley et al.
patent: 2002/0022662 (2002-02-01), Yardley et al.
patent: 2003/0045583 (2003-03-01), Hadfield et al.
patent: 2004/0106818 (2004-06-01), Zhiyin et al.
patent: 2005/0096479 (2005-05-01), Hadfield et al.
patent: 2005/0197392 (2005-09-01), Jerussi et al.
patent: 2006/0047125 (2006-03-01), Leonardi et al.
patent: 2007/0135449 (2007-06-01), Mahaney et al.
patent: 1240206 (2000-01-01), None
patent: 0 112 669 (1984-07-01), None
patent: 2 173 787 (1986-10-01), None
patent: WO 9620160 (1996-07-01), None
patent: WO 00/59851 (2000-10-01), None
patent: WO 02/18325 (2002-03-01), None
patent: WO 02/50017 (2002-06-01), None
patent: WO 02/064543 (2002-08-01), None
patent: WO 2007/011594 (2007-01-01), None
patent: WO 2007/120923 (2007-10-01), None
patent: WO 2008/015584 (2008-02-01), None
patent: WO 2008/017886 (2008-02-01), None
patent: WO 2008/047167 (2008-04-01), None
Yardley, John P., et al., 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine Derivatives: Synthesis and Antidepressant Activity, J. Med. Chem. (1990) 33, pp. 2899-2905, XP000891765.
Klamerus, K.J. et al., “Introduction of the Composite Parameter to the Pharmokinetics of Venlafaxine and its Active O-Desmethyl Metabolite,” J. Clin. Pharmacol. (1992) vol. 32(8), pp. 716-724.
Database Beilstein, Beilstein Institute for Organic Chemistry, retrieved from XFIRE, XP002466133; Database accession No. BRN 4915303 abstract & Bull. Soc. Chim. Fr (1967) pp. 2110-2116.
International Search Report of PCT/US2008/013170 dated Sep. 29, 2009.
G.P.R. Carr, “The Development of British Pharmacopoeia Monographs for Idoxuridine and Idoxuridine Eye Drops Using High-Pressure Liquid Chromatography for Essay and for Controlling Related Impurities”, Journal of Chromatography, 157 (1978), pp. 171-184.
Hicks, David. R. et al., “A High-Performance Liquid Chromatographic Methods for the Simultaneous Determination of Venlafaxine and O-Desmethylvenlafaxine in Biological Fluids”, Therapeutic Drug Monitoring, vol. 16, (1994), pp. 100-107.
Kumar, Phani. A. et al., “A Validated Reversed Phase HPLC Method for the Determination of Process-Related Impurities in Almotriptan Malate API”, Journal of Pharmaceutical and Biomedical Analysis, vol. 46, No. 4, (2007),pp. 792-798.
Rao, Nageswara. R. et al., “An Overview of the Recent Trends in Development of HPLC Methods for Determination of Impurities in Drugs”, Journal of Pharmaceutical and Biomedical Analysis, vol. 33, No. 3, (2003), pp. 335-377.
Lancry Eli
Levi Sigalit
Nidam Tamar
Niddam-Hildesheim Valerie
Shachan-tov Sharona
Katakam Sudhakar
Kenyon & Kenyon LLP
Teva Pharmaceutical Industries Ltd.
LandOfFree
Crystal forms of O-desmethylvenlafaxine fumarate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal forms of O-desmethylvenlafaxine fumarate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal forms of O-desmethylvenlafaxine fumarate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280313